Results 121 to 130 of about 2,749 (135)

Tenofovir Alafenamide: A Review in Chronic Hepatitis B

Drugs, 2017
Henry Lik-Yuen Chan
exaly  

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

Journal of Gastroenterology and Hepatology (Australia), 2019
Mao Okada, Sakura Kirino, Namiki Izumi
exaly  

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Journal of Hepatology, 2015
Stephen D Ryder, Graham R Foster, Kosh Agarwal   +2 more
exaly  

Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)

Biochemical Pharmacology, 2016
Erik De Clercq
exaly  

Tenofovir Alafenamide: A Review of Its Use in the Treatment of HIV-1 Infection

Annals of Pharmacotherapy, 2016

exaly  

Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate

Journal of Antimicrobial Chemotherapy, 2019
Sybil G Hosek, Kristina M Brooks, Samantha Mawhinney   +2 more
exaly  

Tenofovir

Reactions Weekly, 2012
openaire   +1 more source

Tenofovir

Reactions Weekly, 2003
openaire   +2 more sources

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

Clinical Pharmacokinetics, 2012
Jaymin Shāh, Lijie Zhong, Kitty Yale
exaly  

Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence

Therapeutic Advances in Gastroenterology, 2018
Ivana Carey, Kosh Agarwal, Ruth Byrne
exaly